|Bid||464.98 x 800|
|Ask||600.00 x 900|
|Day's range||529.70 - 551.71|
|52-week range||438.72 - 672.34|
|Beta (5Y monthly)||0.83|
|PE ratio (TTM)||27.85|
|Earnings date||26 Jul 2022 - 01 Aug 2022|
|Forward dividend & yield||1.20 (0.22%)|
|Ex-dividend date||14 Jun 2022|
|1y target est||669.53|
Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
WALTHAM, Mass., May 19, 2022--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on May 18, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on July 15, 2022, to shareholders of record as of June 15, 2022.
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Micron Technology, Inc. (MU), and UBS Group AG (UBS).